Nancy A. Speck - Publications

Affiliations: 
Molecular and Cellular Biology Dartmouth College, Hanover, NH, United States 
Area:
Molecular Biology, Biogeochemistry

158 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Wilken MB, Fonar G, Nations C, Pavani G, Tsao V, Garifallou J, Tober J, Bennett L, Maguire JA, Gagne A, Okoli N, Gadue P, Chou ST, Speck NA, French DL, et al. Tropomyosin 1 deficiency facilitates cell state transitions to enhance hemogenic endothelial cell specification during hematopoiesis. Biorxiv : the Preprint Server For Biology. PMID 37693628 DOI: 10.1101/2023.09.01.555861  0.38
2023 Ernst MPT, Pronk E, van Dijk C, van Strien PMH, van Tienhoven TVD, Wevers MJW, Sanders MA, Bindels EMJ, Speck NA, Raaijmakers MHGP. Hematopoietic Cell Autonomous Disruption of Hematopoiesis in a Germline Loss-of-function Mouse Model of -FPD. Hemasphere. 7: e824. PMID 36741355 DOI: 10.1097/HS9.0000000000000824  0.318
2022 Speck NA. A Pernicious Cycle Affecting Premalignant Stem Cells. The New England Journal of Medicine. 386: 596-598. PMID 35139279 DOI: 10.1056/NEJMcibr2117528  0.309
2022 Bennett LF, Mumau MD, Li Y, Speck NA. MyD88-dependent TLR signaling oppositely regulates hematopoietic progenitor and stem cell formation in the embryo. Development (Cambridge, England). PMID 35043940 DOI: 10.1242/dev.200025  0.362
2021 Howell ED, Yzaguirre AD, Gao P, Lis R, He B, Lakadamyali M, Rafii S, Tan K, Speck NA. Efficient hemogenic endothelial cell specification by RUNX1 is dependent on baseline chromatin accessibility of RUNX1-regulated TGFβ target genes. Genes & Development. 35: 1475-1489. PMID 34675061 DOI: 10.1101/gad.348738.121  0.335
2021 Estevez B, Borst S, Jarocha DJ, Sudunagunta VS, Gonzalez M, Garifallou J, Hakonarson H, Gao P, Tan K, Liu PP, Bagga S, Holdreith N, Tong W, Speck NA, French DL, et al. RUNX1 haploinsufficiency causes a marked deficiency of megakaryocyte-biased hematopoietic progenitor cells. Blood. PMID 33569577 DOI: 10.1182/blood.2020006389  0.352
2020 Hsu J, Huang HT, Lee CT, Choudhuri A, Wilson NK, Abraham BJ, Moignard V, Kucinski I, Yu S, Hyde RK, Tober J, Cai X, Li Y, Guo Y, Yang S, ... ... Speck NA, et al. CHD7 and Runx1 interaction provides a braking mechanism for hematopoietic differentiation. Proceedings of the National Academy of Sciences of the United States of America. PMID 32883883 DOI: 10.1073/Pnas.2003228117  0.497
2020 Gao P, Chen C, Howell ED, Li Y, Tober J, Uzun Y, He B, Gao L, Zhu Q, Siekmann AF, Speck NA, Tan K. Transcriptional regulatory network controlling the ontogeny of hematopoietic stem cells. Genes & Development. PMID 32499402 DOI: 10.1101/Gad.338202.120  0.453
2020 Howell ED, Speck NA. Forks in the road to the first hematopoietic stem cells. Cell Research. PMID 32398861 DOI: 10.1038/S41422-020-0331-8  0.43
2020 Zhu Q, Gao P, Tober J, Bennett L, Chen C, Uzun Y, Li Y, Howell ED, Mumau M, Yu W, He B, Speck NA, Tan K. Developmental trajectory of pre-hematopoietic stem cell formation from endothelium. Blood. PMID 32392346 DOI: 10.1182/Blood.2020004801  0.495
2020 Yang W, Trahan GD, Howell ED, Speck NA, Jones KL, Gillen AE, Riemondy K, Hesselberth J, Bryder D, Ernst P. Enhancing Hematopoiesis from Murine Embryonic Stem Cells through MLL1-Induced Activation of a Rac/Rho/Integrin Signaling Axis. Stem Cell Reports. PMID 31951812 DOI: 10.1016/J.Stemcr.2019.12.009  0.472
2019 Chen C, Yu W, Tober J, Gao P, He B, Lee K, Trieu T, Blobel GA, Speck NA, Tan K. Spatial Genome Re-organization between Fetal and Adult Hematopoietic Stem Cells. Cell Reports. 29: 4200-4211.e7. PMID 31851943 DOI: 10.1016/J.Celrep.2019.11.065  0.413
2019 Bennett L, Mumau M, Speck NA. Macrophages Fertilize the Soil to Promote Hematopoietic Cell Growth. Immunity. 50: 1342-1344. PMID 31216456 DOI: 10.1016/J.Immuni.2019.05.017  0.388
2019 Speck N, Zhu Q, Gao P, Tober J, Bennett L, Chen C, Uzun Y, Li Y, Tan K. Developmental Biology of the Blood System Blood. 134: SCI-29-SCI-29. DOI: 10.1182/Blood-2019-121283  0.451
2019 Howell E, He B, Lakadamyali M, Speck N, Tan K, Gao P, Yzaguirre A. 2010 - IDENTIFYING NECESSARY CHROMATIN STATES AND TARGETS FOR HEMOGENIC SPECIFICATION AND REPROGRAMMING Experimental Hematology. 76: S45. DOI: 10.1016/J.Exphem.2019.06.284  0.425
2018 Gao L, Tober J, Gao P, Chen C, Zhu Q, Tan K, Speck NA. RUNX1 and the endothelial origin of blood. Experimental Hematology. PMID 30391350 DOI: 10.1016/J.Exphem.2018.10.009  0.467
2018 Cai X, Zheng Y, Speck NA. A Western Blotting Protocol for Small Numbers of Hematopoietic Stem Cells. Journal of Visualized Experiments : Jove. PMID 30199018 DOI: 10.3791/56855  0.455
2018 Yzaguirre AD, Howell ED, Li Y, Liu Z, Speck NA. Runx1 is sufficient for blood cell formation from non-hemogenic endothelial cells in vivo only during early embryogenesis. Development (Cambridge, England). PMID 29361566 DOI: 10.1242/Dev.158162  0.466
2018 Zhu Q, Tober J, Li Y, Bennett L, Yzaguirre A, Gao P, Tan K, Speck NA. Hematopoietic cell formation in the major arteries of the mouse embryo Experimental Hematology. 64: S23. DOI: 10.1016/J.Exphem.2018.06.005  0.382
2017 Kulkeaw K, Inoue T, Iino T, Tani K, Akashi K, Speck NA, Nakanishi Y, Sugiyama D. Twist1 regulates embryonic hematopoietic differentiation through binding to Myb and Gata2 promoter regions. Blood Advances. 1: 1672-1681. PMID 29296814 DOI: 10.1182/Bloodadvances.2017006056  0.461
2017 Tober J, Maijenburg MMW, Li Y, Gao L, Hadland BK, Gao P, Minoura K, Bernstein ID, Tan K, Speck NA. Maturation of hematopoietic stem cells from prehematopoietic stem cells is accompanied by up-regulation of PD-L1. The Journal of Experimental Medicine. PMID 29282253 DOI: 10.1084/Jem.20161594  0.366
2017 Oo ZM, Illendula A, Grembecka J, Schmidt C, Zhou Y, Esain V, Kwan W, Frost I, North TE, Rajewski RA, Speck NA, Bushweller JH. A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells. Leukemia & Lymphoma. 1-13. PMID 29249175 DOI: 10.1080/10428194.2017.1410882  0.476
2017 Zhen T, Kwon E, Zhao L, Hsu J, Hyde RK, Lu Y, Alemu L, Speck NA, Liu PP. CHD7 deficiency delays leukemogenesis in mice induced by CBFB-MYH11. Blood. PMID 29018080 DOI: 10.1182/Blood-2017-04-780106  0.394
2017 Li Y, Gao L, Hadland B, Tan K, Speck NA. CD27 marks murine embryonic hematopoietic stem cells and type II pre-hematopoietic stem cells. Blood. PMID 28588017 DOI: 10.1182/Blood-2017-03-776849  0.476
2017 Kim E, Cheng Y, Bolton-Gillespie E, Cai X, Ma C, Tarangelo A, Le L, Jambhekar M, Raman P, Hayer KE, Wertheim G, Speck NA, Tong W, Viatour P. Rb family proteins enforce the homeostasis of quiescent hematopoietic stem cells by repressing Socs3 expression. The Journal of Experimental Medicine. PMID 28550162 DOI: 10.1084/Jem.20160719  0.424
2017 Lis R, Karrasch CC, Poulos MG, Kunar B, Redmond D, Duran JGB, Badwe CR, Schachterle W, Ginsberg M, Xiang J, Tabrizi AR, Shido K, Rosenwaks Z, Elemento O, Speck NA, et al. Conversion of adult endothelium to immunocompetent haematopoietic stem cells. Nature. PMID 28514438 DOI: 10.1038/Nature22326  0.48
2017 Yzaguirre AD, de Bruijn MF, Speck NA. The Role of Runx1 in Embryonic Blood Cell Formation. Advances in Experimental Medicine and Biology. 962: 47-64. PMID 28299650 DOI: 10.1007/978-981-10-3233-2_4  0.482
2017 Lis R, Karrasch C, Poulos M, Kunar B, Redmond D, Duran JGB, Badwe C, Ginsberg M, Schachterle W, Xiang J, Tabrizi AR, Shido K, Rosenwaks Z, Elemento O, Speck N, et al. Conversion of adult endothelium into immune-competent haematopoietic stem cells Experimental Hematology. 53. DOI: 10.1016/J.Exphem.2017.06.183  0.363
2016 Speck NA. Stress Can Be a Good Thing for Blood Formation. Cell Stem Cell. 19: 279-80. PMID 27588740 DOI: 10.1016/J.Stem.2016.08.011  0.351
2016 Yzaguirre AD, Speck NA. Insights into blood cell formation from hemogenic endothelium in lesser-known anatomic sites. Developmental Dynamics : An Official Publication of the American Association of Anatomists. PMID 27389484 DOI: 10.1002/Dvdy.24430  0.43
2016 Tober J, Maijenburg MW, Speck NA. Taking the Leap: Runx1 in the Formation of Blood from Endothelium. Current Topics in Developmental Biology. 118: 113-62. PMID 27137656 DOI: 10.1016/Bs.Ctdb.2016.01.008  0.466
2016 Yzaguirre AD, Speck NA. Extravascular endothelial and hematopoietic islands form through multiple pathways in midgestation mouse embryos. Developmental Biology. PMID 27105579 DOI: 10.1016/J.Ydbio.2016.04.004  0.392
2016 Cai X, Hayashi Y, Wunderlich M, Speck NA, Mulloy JC, Huang G, Zheng Y. Loss of Function RUNX1 Mutations Restrict Protein Biosynthesis during Pre-Leukemia and MDS Transition but Not after Leukemic Transformation Blood. 128: 3860-3860. DOI: 10.1182/Blood.V128.22.3860.3860  0.452
2016 Lis R, Harrasch C, Poulos MG, Duran JG, Schachterle W, Ginsberg M, Rafii A, Shido K, Speck NA, Butler JM, Scandura JM, Rafii S. Direct Conversion of Adult Endothelial Cells into Immunecompetent Long-Term Engraftable Clinically Scalable Hematopoietic Stem Cells: Pathway to Therapeutic Translation Blood. 128: 372-372. DOI: 10.1182/Blood.V128.22.372.372  0.482
2016 Lis R, Karrasch C, Poulos M, Barcia Duran JG, Schachterle W, Ginsberg M, Tabrizi AR, Shido K, Speck N, Butler J, Scandura J, Rafii S. Step-wise reprogramming of endothelial cells into immune-competent hematopoietic stem cells Experimental Hematology. 44: S48-S49. DOI: 10.1016/J.Exphem.2016.06.065  0.425
2016 Speck N. Expression and epigenomic profiling of embryonic hematopoiesis Experimental Hematology. 44: S37. DOI: 10.1016/J.Exphem.2016.06.035  0.301
2015 Yzaguirre AD, Padmanabhan A, de Groh ED, Engleka KA, Li J, Speck NA, Epstein JA. Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos. Elife. 4. PMID 26460546 DOI: 10.7554/Elife.07780  0.304
2015 Cai X, Gao L, Teng L, Ge J, Oo ZM, Kumar AR, Gilliland DG, Mason PJ, Tan K, Speck NA. Runx1 Deficiency Decreases Ribosome Biogenesis and Confers Stress Resistance to Hematopoietic Stem and Progenitor Cells. Cell Stem Cell. 17: 165-77. PMID 26165925 DOI: 10.1016/J.Stem.2015.06.002  0.46
2015 Ohta Y, Okabe T, Larmour C, Di Rocco A, Maijenburg M, Phillips A, Speck NA, Wakitani S, Nakamura T, Yamada Y, Enomoto-Iwamoto M, Pacifici M, Iwamoto M. Articular cartilage endurance and resistance to osteoarthritic changes require transcription factor Erg. Arthritis & Rheumatology (Hoboken, N.J.). PMID 26097038 DOI: 10.1002/Art.39243  0.336
2015 Ditadi A, Sturgeon CM, Tober J, Awong G, Kennedy M, Yzaguirre AD, Azzola L, Ng ES, Stanley EG, French DL, Cheng X, Gadue P, Speck NA, Elefanty AG, Keller G. Human definitive haemogenic endothelium and arterial vascular endothelium represent distinct lineages. Nature Cell Biology. 17: 580-91. PMID 25915127 DOI: 10.1038/Ncb3161  0.348
2015 Maretzky T, Evers A, Le Gall S, Alabi RO, Speck N, Reiss K, Blobel CP. The cytoplasmic domain of a disintegrin and metalloproteinase 10 (ADAM10) regulates its constitutive activity but is dispensable for stimulated ADAM10-dependent shedding. The Journal of Biological Chemistry. 290: 7416-25. PMID 25605720 DOI: 10.1074/Jbc.M114.603753  0.332
2015 Tamplin OJ, Durand EM, Carr LA, Childs SJ, Hagedorn EJ, Li P, Yzaguirre AD, Speck NA, Zon LI. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell. 160: 241-52. PMID 25594182 DOI: 10.1016/J.Cell.2014.12.032  0.48
2014 Li Y, Esain V, Teng L, Xu J, Kwan W, Frost IM, Yzaguirre AD, Cai X, Cortes M, Maijenburg MW, Tober J, Dzierzak E, Orkin SH, Tan K, North TE, ... Speck NA, et al. Inflammatory signaling regulates embryonic hematopoietic stem and progenitor cell production. Genes & Development. 28: 2597-612. PMID 25395663 DOI: 10.1101/Gad.253302.114  0.405
2014 Satpathy AT, Briseño CG, Cai X, Michael DG, Chou C, Hsiung S, Bhattacharya D, Speck NA, Egawa T. Runx1 and Cbfβ regulate the development of Flt3+ dendritic cell progenitors and restrict myeloproliferative disorder. Blood. 123: 2968-77. PMID 24677539 DOI: 10.1182/Blood-2013-11-539643  0.47
2014 Gerhardt DM, Pajcini KV, D'altri T, Tu L, Jain R, Xu L, Chen MJ, Rentschler S, Shestova O, Wertheim GB, Tobias JW, Kluk M, Wood AW, Aster JC, Gimotty PA, ... ... Speck N, et al. The Notch1 transcriptional activation domain is required for development and reveals a novel role for Notch1 signaling in fetal hematopoietic stem cells. Genes & Development. 28: 576-93. PMID 24637115 DOI: 10.1101/Gad.227496.113  0.476
2014 Imanirad P, Solaimani Kartalaei P, Crisan M, Vink C, Yamada-Inagawa T, de Pater E, Kurek D, Kaimakis P, van der Linden R, Speck N, Dzierzak E. HIF1α is a regulator of hematopoietic progenitor and stem cell development in hypoxic sites of the mouse embryo. Stem Cell Research. 12: 24-35. PMID 24141110 DOI: 10.1016/J.Scr.2013.09.006  0.502
2014 Li Y, Esain V, Teng L, Xu J, Frost I, Kwan W, Yzaguirre AD, Maijenberg MW, Orkin SH, Tan K, North TE, Speck NA. Inflammatory Signaling Regulates Embryonic Hematopoietic Stem and Lymphoid Progenitor Cell Formation Blood. 124: 2902-2902. DOI: 10.1182/Blood.V124.21.2902.2902  0.464
2014 Speck N, Li Y, Esain V, Teng L, Xu J, Phillips-Yzaguirre A, Maijenburg M, Dzierzak E, Orkin S, Tan K, North T. Inflammatory signaling regulates the number of lymphoid progenitors and HSCs in the embryo Experimental Hematology. 42: S5. DOI: 10.1016/J.Exphem.2014.07.018  0.314
2013 de Pater E, Kaimakis P, Vink CS, Yokomizo T, Yamada-Inagawa T, van der Linden R, Kartalaei PS, Camper SA, Speck N, Dzierzak E. Gata2 is required for HSC generation and survival. The Journal of Experimental Medicine. 210: 2843-50. PMID 24297996 DOI: 10.1084/Jem.20130751  0.471
2013 Tober J, Yzaguirre AD, Piwarzyk E, Speck NA. Distinct temporal requirements for Runx1 in hematopoietic progenitors and stem cells. Development (Cambridge, England). 140: 3765-76. PMID 23924635 DOI: 10.1242/Dev.094961  0.466
2013 Clarke RL, Yzaguirre AD, Yashiro-Ohtani Y, Bondue A, Blanpain C, Pear WS, Speck NA, Keller G. The expression of Sox17 identifies and regulates haemogenic endothelium. Nature Cell Biology. 15: 502-10. PMID 23604320 DOI: 10.1038/Ncb2724  0.462
2013 Richard C, Drevon C, Canto PY, Villain G, Bollérot K, Lempereur A, Teillet MA, Vincent C, Rosselló Castillo C, Torres M, Piwarzyk E, Speck NA, Souyri M, Jaffredo T. Endothelio-mesenchymal interaction controls runx1 expression and modulates the notch pathway to initiate aortic hematopoiesis. Developmental Cell. 24: 600-11. PMID 23537631 DOI: 10.1016/J.Devcel.2013.02.011  0.415
2013 DeKelver RC, Yan M, Ahn EY, Shia WJ, Speck NA, Zhang DE. Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. Blood. 121: 3714-7. PMID 23426948 DOI: 10.1182/Blood-2012-11-465641  0.427
2013 Hsu J, Huang H, Lee C, Yu S, Zon LI, Speck NA. Chromatin Remodeling Enzyme CHD7 Negatively Regulate Hematopoietic Stem Cell Function Blood. 122: 2413-2413. DOI: 10.1182/Blood.V122.21.2413.2413  0.53
2013 Kaimakis P, Eich C, de Pater E, van der Linden R, Speck N, Meijer D, Dzierzak E. Transcriptional control of hematopoiesis during embryonic development Experimental Hematology. 41: S44. DOI: 10.1016/J.Exphem.2013.05.175  0.317
2012 Chou ST, Byrska-Bishop M, Tober JM, Yao Y, Vandorn D, Opalinska JB, Mills JA, Choi JK, Speck NA, Gadue P, Hardison RC, Nemiroff RL, French DL, Weiss MJ. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells. Proceedings of the National Academy of Sciences of the United States of America. 109: 17573-8. PMID 23045704 DOI: 10.1073/Pnas.1211175109  0.407
2012 Guo H, Ma O, Speck NA, Friedman AD. Runx1 deletion or dominant inhibition reduces Cebpa transcription via conserved promoter and distal enhancer sites to favor monopoiesis over granulopoiesis. Blood. 119: 4408-18. PMID 22451420 DOI: 10.1182/Blood-2011-12-397091  0.486
2012 Soung do Y, Talebian L, Matheny CJ, Guzzo R, Speck ME, Lieberman JR, Speck NA, Drissi H. Runx1 dose-dependently regulates endochondral ossification during skeletal development and fracture healing. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 27: 1585-97. PMID 22431360 DOI: 10.1002/Jbmr.1601  0.768
2012 Hsu J, Huang H, Lee C, Yu S, Gerber S, Zon LI, Speck NA. CHD7 Negatively Regulates Hematopoietic Stem Cell Potency Blood. 120: 850-850. DOI: 10.1182/Blood.V120.21.850.850  0.51
2011 Mangan JK, Speck NA. RUNX1 mutations in clonal myeloid disorders: from conventional cytogenetics to next generation sequencing, a story 40 years in the making. Critical Reviews in Oncogenesis. 16: 77-91. PMID 22150309 DOI: 10.1615/Critrevoncog.V16.I1-2.80  0.317
2011 Cai X, Gaudet JJ, Mangan JK, Chen MJ, De Obaldia ME, Oo Z, Ernst P, Speck NA. Runx1 loss minimally impacts long-term hematopoietic stem cells. Plos One. 6: e28430. PMID 22145044 DOI: 10.1371/Journal.Pone.0028430  0.809
2011 Chen MJ, Li Y, De Obaldia ME, Yang Q, Yzaguirre AD, Yamada-Inagawa T, Vink CS, Bhandoola A, Dzierzak E, Speck NA. Erythroid/myeloid progenitors and hematopoietic stem cells originate from distinct populations of endothelial cells. Cell Stem Cell. 9: 541-52. PMID 22136929 DOI: 10.1016/J.Stem.2011.10.003  0.521
2011 Pajcini KV, Speck NA, Pear WS. Notch signaling in mammalian hematopoietic stem cells Leukemia. 25: 1525-1532. PMID 21647159 DOI: 10.1038/Leu.2011.127  0.445
2011 Hsu J, Lee C, Gerber S, Yu S, Speck NA. Runx1-Cbfb Interacts with CHD7, a Chromatin Modifying Enzyme with a Potential Role in Hematopoiesis Blood. 118: 1300-1300. DOI: 10.1182/Blood.V118.21.1300.1300  0.532
2010 Swiers G, de Bruijn M, Speck NA. Hematopoietic stem cell emergence in the conceptus and the role of Runx1. The International Journal of Developmental Biology. 54: 1151-63. PMID 20711992 DOI: 10.1387/Ijdb.103106Gs  0.516
2010 Corpora T, Roudaia L, Oo ZM, Chen W, Manuylova E, Cai X, Chen MJ, Cierpicki T, Speck NA, Bushweller JH. Structure of the AML1-ETO NHR3-PKA(RIIα) complex and its contribution to AML1-ETO activity. Journal of Molecular Biology. 402: 560-77. PMID 20708017 DOI: 10.1016/J.Jmb.2010.08.007  0.389
2010 Sinenko SA, Hung T, Moroz T, Tran QM, Sidhu S, Cheney MD, Speck NA, Banerjee U. Genetic manipulation of AML1-ETO-induced expansion of hematopoietic precursors in a Drosophila model. Blood. 116: 4612-20. PMID 20688956 DOI: 10.1182/Blood-2010-03-276998  0.399
2010 Speck NA, Vakoc CR. PAF is in the cabal of MLL1-interacting proteins that promote leukemia. Cancer Cell. 17: 531-2. PMID 20541697 DOI: 10.1016/J.Ccr.2010.05.019  0.379
2009 Hollenhorst PC, Chandler KJ, Poulsen RL, Johnson WE, Speck NA, Graves BJ. DNA specificity determinants associate with distinct transcription factor functions. Plos Genetics. 5: e1000778. PMID 20019798 DOI: 10.1371/Journal.Pgen.1000778  0.391
2009 Speck NA, Iruela-Arispe ML. Conditional Cre/LoxP strategies for the study of hematopoietic stem cell formation. Blood Cells, Molecules & Diseases. 43: 6-11. PMID 19250847 DOI: 10.1016/J.Bcmd.2009.01.010  0.428
2009 Park S, Chen W, Cierpicki T, Tonelli M, Cai X, Speck NA, Bushweller JH. Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity. Blood. 113: 3558-67. PMID 19204326 DOI: 10.1182/Blood-2008-06-161307  0.408
2009 Roudaia L, Cheney MD, Manuylova E, Chen W, Morrow M, Park S, Lee CT, Kaur P, Williams O, Bushweller JH, Speck NA. CBFbeta is critical for AML1-ETO and TEL-AML1 activity. Blood. 113: 3070-9. PMID 19179469 DOI: 10.1182/Blood-2008-03-147207  0.474
2009 Chen MJ, Yokomizo T, Zeigler BM, Dzierzak E, Speck NA. Runx1 is required for the endothelial to haematopoietic cell transition but not thereafter. Nature. 457: 887-91. PMID 19129762 DOI: 10.1038/Nature07619  0.78
2008 Roudaia L, Speck NA. A MENage à Trois in leukemia. Cancer Cell. 14: 3-5. PMID 18598937 DOI: 10.1016/J.Ccr.2008.06.009  0.328
2008 Guo Y, Maillard I, Chakraborti S, Rothenberg EV, Speck NA. Core binding factors are necessary for natural killer cell development and cooperate with Notch signaling during T-cell specification. Blood. 112: 480-92. PMID 18390836 DOI: 10.1182/Blood-2007-10-120261  0.504
2008 Jude CD, Gaudet JJ, Speck NA, Ernst P. Leukemia and hematopoietic stem cells: balancing proliferation and quiescence. Cell Cycle (Georgetown, Tex.). 7: 586-91. PMID 18239455 DOI: 10.4161/Cc.7.5.5549  0.809
2008 Dzierzak E, Speck NA. Of lineage and legacy: the development of mammalian hematopoietic stem cells. Nature Immunology. 9: 129-36. PMID 18204427 DOI: 10.1038/Ni1560  0.456
2008 Huang G, Zhang P, Hirai H, Elf S, Yan X, Chen Z, Koschmieder S, Okuno Y, Dayaram T, Growney JD, Shivdasani RA, Gilliland DG, Speck NA, Nimer SD, Tenen DG. PU.1 is a major downstream target of AML1 (RUNX1) in adult mouse hematopoiesis. Nature Genetics. 40: 51-60. PMID 17994017 DOI: 10.1038/Ng.2007.7  0.43
2008 Speck NA, Chen M, Yokomizo T, Zeigler B, Dzierzak E. Runx1 Interactions in Stem Cell Biology. Blood. 112: sci-15-sci-15. DOI: 10.1182/Blood.V112.11.Sci-15.Sci-15  0.455
2007 Gorczynski MJ, Grembecka J, Zhou Y, Kong Y, Roudaia L, Douvas MG, Newman M, Bielnicka I, Baber G, Corpora T, Shi J, Sridharan M, Lilien R, Donald BR, Speck NA, et al. Allosteric inhibition of the protein-protein interaction between the leukemia-associated proteins Runx1 and CBFbeta. Chemistry & Biology. 14: 1186-97. PMID 17961830 DOI: 10.1016/J.Chembiol.2007.09.006  0.36
2007 Liu Y, Chen W, Gaudet J, Cheney MD, Roudaia L, Cierpicki T, Klet RC, Hartman K, Laue TM, Speck NA, Bushweller JH. Structural basis for recognition of SMRT/N-CoR by the MYND domain and its contribution to AML1/ETO's activity. Cancer Cell. 11: 483-97. PMID 17560331 DOI: 10.1016/J.Ccr.2007.04.010  0.781
2007 Matheny CJ, Speck ME, Cushing PR, Zhou Y, Corpora T, Regan M, Newman M, Roudaia L, Speck CL, Gu TL, Griffey SM, Bushweller JH, Speck NA. Disease mutations in RUNX1 and RUNX2 create nonfunctional, dominant-negative, or hypomorphic alleles. The Embo Journal. 26: 1163-75. PMID 17290219 DOI: 10.1038/Sj.Emboj.7601568  0.331
2007 Talebian L, Li Z, Guo Y, Gaudet J, Speck ME, Sugiyama D, Kaur P, Pear WS, Maillard I, Speck NA. T-lymphoid, megakaryocyte, and granulocyte development are sensitive to decreases in CBFbeta dosage. Blood. 109: 11-21. PMID 16940420 DOI: 10.1182/Blood-2006-05-021188  0.774
2007 Douvas MG, Roudaiya L, Grembecka J, Speck N, Bushweller J. Development of Allosteric Inhibitors of the Interaction of AML1 and CBFβ for the Treatment of Leukemia. Blood. 110: 653-653. DOI: 10.1182/Blood.V110.11.653.653  0.428
2007 Grembecka JE, Graf K, Kong Y, Douvas M, Cierpicki T, Illendula A, Baber G, Bielnicka I, Roudaia L, Speck NA, Brown ML, Bushweller JH. Development of Small Molecule Inhibitors of the AML1-ETO and CBFβ-SMMHC Oncoproteins. Blood. 110: 1591-1591. DOI: 10.1182/Blood.V110.11.1591.1591  0.386
2006 Li Z, Lukasik SM, Liu Y, Grembecka J, Bielnicka I, Bushweller JH, Speck NA. A mutation in the S-switch region of the Runt domain alters the dynamics of an allosteric network responsible for CBFbeta regulation. Journal of Molecular Biology. 364: 1073-83. PMID 17059830 DOI: 10.1016/J.Jmb.2006.10.002  0.389
2006 Zeigler BM, Sugiyama D, Chen M, Guo Y, Downs KM, Speck NA. The allantois and chorion, when isolated before circulation or chorio-allantoic fusion, have hematopoietic potential. Development (Cambridge, England). 133: 4183-92. PMID 17038514 DOI: 10.1242/Dev.02596  0.787
2006 Liu Y, Cheney MD, Gaudet JJ, Chruszcz M, Lukasik SM, Sugiyama D, Lary J, Cole J, Dauter Z, Minor W, Speck NA, Bushweller JH. The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. Cancer Cell. 9: 249-60. PMID 16616331 DOI: 10.1016/J.Ccr.2006.03.012  0.782
2006 Li Z, Chen MJ, Stacy T, Speck NA. Runx1 function in hematopoiesis is required in cells that express Tek. Blood. 107: 106-10. PMID 16174759 DOI: 10.1182/Blood-2005-05-1955  0.428
2005 Kundu M, Compton S, Garrett-Beal L, Stacy T, Starost MF, Eckhaus M, Speck NA, Liu PP. Runx1 deficiency predisposes mice to T-lymphoblastic lymphoma. Blood. 106: 3621-4. PMID 16051740 DOI: 10.1182/Blood-2005-04-1447  0.47
2005 Growney JD, Shigematsu H, Li Z, Lee BH, Adelsperger J, Rowan R, Curley DP, Kutok JL, Akashi K, Williams IR, Speck NA, Gilliland DG. Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype. Blood. 106: 494-504. PMID 15784726 DOI: 10.1182/Blood-2004-08-3280  0.428
2005 Sugiyama D, Sugiyama H, Speck NA. A Role for Twist in Thymocyte Development. Blood. 106: 4252-4252. DOI: 10.1182/Blood.V106.11.4252.4252  0.498
2005 Cheney MD, Liu Y, Gaudet JJ, Chruszcz M, Lukasik SM, Sugiyama D, Lary J, Cole J, Dauter Z, Minor W, Speck NA, Bushweller JH. Structural and Functional Characterization of the NHR2 and Runt Domains of AML1/ETO. Blood. 106: 2854-2854. DOI: 10.1182/Blood.V106.11.2854.2854  0.803
2005 Guo Y, Talebian L, Maillard I, Speck CL, Pear WS, Rothenberg EV, Speck NA. Reduction of Core Binding Factor beta (CBFβ) Dosage Blocks T Cell Development. Blood. 106: 2714-2714. DOI: 10.1182/Blood.V106.11.2714.2714  0.821
2005 Bushweller JH, Lukasik SM, Speck NA. The CBFb-SMMHC Oncoprotein Inhibits Binding of the Runx1 Runt Domain to DNA. Blood. 106: 2709-2709. DOI: 10.1182/Blood.V106.11.2709.2709  0.443
2005 Grembecka J, Graf K, Newman M, Zhou Y, Cheney M, Speck NA, Brown ML, Bushweller JH. Development of Small Molecule Inhibitor of the AML1-ETO Oncoprotein. Blood. 106: 1515-1515. DOI: 10.1182/Blood.V106.11.1515.1515  0.378
2005 Maillard I, Talebian L, Li Z, Guo Y, Sugiyama D, Speck ME, Pear WS, Speck NA. A Hypomorphic Cbfb Allele Reveals a Critical Dosage-Sensitive Function of Core Binding Factors at the Earliest Stages of T Cell Development. Blood. 106: 124-124. DOI: 10.1182/Blood.V106.11.124.124  0.819
2004 Yamashiro T, Wang XP, Li Z, Oya S, Aberg T, Fukunaga T, Kamioka H, Speck NA, Takano-Yamamoto T, Thesleff I. Possible roles of Runx1 and Sox9 in incipient intramembranous ossification. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 19: 1671-7. PMID 15355562 DOI: 10.1359/Jbmr.040801  0.356
2004 Yan J, Liu Y, Lukasik SM, Speck NA, Bushweller JH. CBFbeta allosterically regulates the Runx1 Runt domain via a dynamic conformational equilibrium. Nature Structural & Molecular Biology. 11: 901-6. PMID 15322525 DOI: 10.1038/Nsmb819  0.346
2004 de Bruijn MF, Speck NA. Core-binding factors in hematopoiesis and immune function. Oncogene. 23: 4238-48. PMID 15156179 DOI: 10.1038/Sj.Onc.1207763  0.435
2004 van Wijnen AJ, Stein GS, Gergen JP, Groner Y, Hiebert SW, Ito Y, Liu P, Neil JC, Ohki M, Speck N. Nomenclature for Runt-related (RUNX) proteins. Oncogene. 23: 4209-10. PMID 15156174 DOI: 10.1038/Sj.Onc.1207758  0.399
2004 North TE, Stacy T, Matheny CJ, Speck NA, de Bruijn MF. Runx1 is expressed in adult mouse hematopoietic stem cells and differentiating myeloid and lymphoid cells, but not in maturing erythroid cells. Stem Cells (Dayton, Ohio). 22: 158-68. PMID 14990855 DOI: 10.1634/Stemcells.22-2-158  0.487
2004 Huang G, Zhang P, Koschmieder S, Growney JD, Gilliland DG, Speck NA, Tenen DG. PU.1 Is a Critical Downstream Target of AML1. Blood. 104: 358-358. DOI: 10.1182/Blood.V104.11.358.358  0.486
2004 Talebian L, Li Z, Gallagher TL, Guo Y, Speck CL, Stacy T, Speck NA. A Hypomorphic Cbfb Allele Reveals Requirements for the Development of T Lymphocytes, Granulocytes, and Monocytes/Macrophages, and for Maintaining Proper Numbers of Hematopoietic Progenitors. Blood. 104: 1596-1596. DOI: 10.1182/Blood.V104.11.1596.1596  0.8
2003 Lian JB, Balint E, Javed A, Drissi H, Vitti R, Quinlan EJ, Zhang L, Wijnen AJV, Stein JL, Speck NA, Stein GS. Runx1/AML1 hematopoietic transcription factor contributes to skeletal development in vivo. Journal of Cellular Physiology. 196: 301-311. PMID 12811823 DOI: 10.1002/Jcp.10316  0.42
2003 Zhang L, Li Z, Yan J, Pradhan P, Corpora T, Cheney MD, Bravo J, Warren AJ, Bushweller JH, Speck NA. Mutagenesis of the Runt domain defines two energetic hot spots for heterodimerization with the core binding factor beta subunit. The Journal of Biological Chemistry. 278: 33097-104. PMID 12807883 DOI: 10.1074/Jbc.M303972200  0.358
2003 Li Z, Yan J, Matheny CJ, Corpora T, Bravo J, Warren AJ, Bushweller JH, Speck NA. Energetic contribution of residues in the Runx1 Runt domain to DNA binding. The Journal of Biological Chemistry. 278: 33088-96. PMID 12807882 DOI: 10.1074/Jbc.M303973200  0.374
2003 Zhang L, Lukasik SM, Speck NA, Bushweller JH. Structural and functional characterization of Runx1, CBF beta, and CBF beta-SMMHC. Blood Cells, Molecules & Diseases. 30: 147-56. PMID 12732176 DOI: 10.1016/S1079-9796(03)00022-6  0.322
2002 Miller J, Horner A, Stacy T, Lowrey C, Lian JB, Stein G, Nuckolls GH, Speck NA. The core-binding factor beta subunit is required for bone formation and hematopoietic maturation. Nature Genetics. 32: 645-9. PMID 12434155 DOI: 10.1038/Ng1049  0.358
2002 Lukasik SM, Zhang L, Corpora T, Tomanicek S, Li Y, Kundu M, Hartman K, Liu PP, Laue TM, Biltonen RL, Speck NA, Bushweller JH. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis. Nature Structural Biology. 9: 674-9. PMID 12172539 DOI: 10.1038/Nsb831  0.334
2002 Speck NA, Gilliland DG. Core-binding factors in haematopoiesis and leukaemia. Nature Reviews. Cancer. 2: 502-13. PMID 12094236 DOI: 10.1038/Nrc840  0.38
2002 Lacaud G, Gore L, Kennedy M, Kouskoff V, Kingsley P, Hogan C, Carlsson L, Speck N, Palis J, Keller G. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro. Blood. 100: 458-66. PMID 12091336 DOI: 10.1182/Blood-2001-12-0321  0.475
2002 North TE, de Bruijn MF, Stacy T, Talebian L, Lind E, Robin C, Binder M, Dzierzak E, Speck NA. Runx1 expression marks long-term repopulating hematopoietic stem cells in the midgestation mouse embryo. Immunity. 16: 661-72. PMID 12049718 DOI: 10.1016/S1074-7613(02)00296-0  0.818
2002 Levanon D, Brenner O, Negreanu V, Bettoun D, Woolf E, Eilam R, Lotem J, Gat U, Otto F, Speck N, Groner Y. Spatial and temporal expression pattern of Runx3 (Aml2) and Runx1 (Aml1) indicates non-redundant functions during mouse embryogenesis. Mechanisms of Development. 109: 413-7. PMID 11731260 DOI: 10.1016/S0925-4773(01)00537-8  0.358
2001 Speck NA. Core binding factor and its role in normal hematopoietic development. Current Opinion in Hematology. 8: 192-6. PMID 11561154 DOI: 10.1097/00062752-200107000-00002  0.468
2001 Miller JD, Stacy T, Liu PP, Speck NA. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells. Blood. 97: 2248-56. PMID 11290585 DOI: 10.1182/Blood.V97.8.2248  0.525
2000 Tracey WD, Speck NA. Potential roles for RUNX1 and its orthologs in determining hematopoietic cell fate. Seminars in Cell & Developmental Biology. 11: 337-42. PMID 11105897 DOI: 10.1006/Scdb.2000.0186  0.469
2000 Tang YY, Shi J, Zhang L, Davis A, Bravo J, Warren AJ, Speck NA, Bushweller JH. Energetic and functional contribution of residues in the core binding factor beta (CBFbeta ) subunit to heterodimerization with CBFalpha. The Journal of Biological Chemistry. 275: 39579-88. PMID 10984496 DOI: 10.1074/Jbc.M007350200  0.404
2000 de Bruijn MF, Speck NA, Peeters MC, Dzierzak E. Definitive hematopoietic stem cells first develop within the major arterial regions of the mouse embryo. The Embo Journal. 19: 2465-74. PMID 10835345 DOI: 10.1093/Emboj/19.11.2465  0.432
2000 Tang YY, Crute BE, Kelley JJ, Huang X, Yan J, Shi J, Hartman KL, Laue TM, Speck NA, Bushweller JH. Biophysical characterization of interactions between the core binding factor alpha and beta subunits and DNA. Febs Letters. 470: 167-72. PMID 10734228 DOI: 10.1016/S0014-5793(00)01312-0  0.339
2000 Gu TL, Goetz TL, Graves BJ, Speck NA. Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1). Molecular and Cellular Biology. 20: 91-103. PMID 10594012 DOI: 10.1128/Mcb.20.1.91-103.2000  0.361
2000 Goetz TL, Gu TL, Speck NA, Graves BJ. Auto-inhibition of Ets-1 is counteracted by DNA binding cooperativity with core-binding factor alpha2. Molecular and Cellular Biology. 20: 81-90. PMID 10594011 DOI: 10.1128/Mcb.20.1.81-90.2000  0.36
2000 de Bruijn MFTR, Peeters MCE, Luteijn T, Visser P, Speck NA, Dzierzak E. CFU-S11 activity does not localize solely with the aorta in the aorta-gonad-mesonephros region Blood. 96: 2902-2904. DOI: 10.1182/Blood.V96.8.2902.H8002902_2902_2904  0.309
1999 Berardi MJ, Sun C, Zehr M, Abildgaard F, Peng J, Speck NA, Bushweller JH. The Ig fold of the core binding factor α Runt domain is a member of a family of structurally and functionally related Ig-fold DNA-binding domains Structure. 7: 1247-1256. PMID 10545320 DOI: 10.1016/S0969-2126(00)80058-1  0.424
1999 Song WJ, Sullivan MG, Legare RD, Hutchings S, Tan X, Kufrin D, Ratajczak J, Resende IC, Haworth C, Hock R, Loh M, Felix C, Roy DC, Busque L, Kurnit D, ... ... Speck NA, et al. Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia. Nature Genetics. 23: 166-75. PMID 10508512 DOI: 10.1038/13793  0.335
1999 Huang X, Peng JW, Speck NA, Bushweller JH. Solution structure of core binding factor beta and map of the CBF alpha binding site. Nature Structural Biology. 6: 624-7. PMID 10404216 DOI: 10.1038/10670  0.325
1999 Lewis AF, Stacy T, Green WR, Taddesse-Heath L, Hartley JW, Speck NA. Core-binding factor influences the disease specificity of Moloney murine leukemia virus. Journal of Virology. 73: 5535-47. PMID 10364302 DOI: 10.1128/Jvi.73.7.5535-5547.1999  0.37
1998 Adya N, Stacy T, Speck NA, Liu PP. The leukemic protein core binding factor beta (CBFbeta)-smooth-muscle myosin heavy chain sequesters CBFalpha2 into cytoskeletal filaments and aggregates. Molecular and Cellular Biology. 18: 7432-43. PMID 9819429 DOI: 10.1128/Mcb.18.12.7432  0.414
1998 Erman B, Cortes M, Nikolajczyk BS, Speck NA, Sen R. ETS-core binding factor: A common composite motif in antigen receptor gene enhancers Molecular and Cellular Biology. 18: 1322-1330. PMID 9488447 DOI: 10.1128/Mcb.18.3.1322  0.442
1998 Huang X, Speck N, Bushweller J. Complete Heteronuclear NMR Resonance Assignments, Secondary Structure, and Mapping of Core Binding Factor a Binding Site for Core Binding Factor b (1-141) Journal of Back and Musculoskeletal Rehabilitation. DOI: 10.13018/Bmr4092  0.32
1997 Cao W, Britos-Bray M, Claxton DF, Kelley CA, Speck NA, Liu PP, Friedman AD. CBFβ-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells Oncogene. 15: 1315-1327. PMID 9315100 DOI: 10.1038/Sj.Onc.1201305  0.422
1997 Yergeau DA, Hetherington CJ, Wang Q, Zhang P, Sharpe AH, Binder M, Marín-Padilla M, Tenen DG, Speck NA, Zhang DE. Embryonic lethality and impairment of haematopoiesis in mice heterozygous for an AML1-ETO fusion gene. Nature Genetics. 15: 303-6. PMID 9054947 DOI: 10.1038/Ng0397-303  0.452
1997 Wang Q, Stacy T, Miller JD, Lewis AF, Gu TL, Huang X, Bushweller JH, Bories JC, Alt FW, Ryan G, Liu PP, Wynshaw-Boris A, Binder M, Marín-Padilla M, Sharpe AH, ... Speck NA, et al. The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo. Cell. 87: 697-708. PMID 8929538 DOI: 10.1016/S0092-8674(00)81389-6  0.391
1996 Castilla LH, Wijmenga C, Wang Q, Stacy T, Speck NA, Eckhaus M, Marín-Padilla M, Collins FS, Wynshaw-Boris A, Liu PP. Failure of embryonic hematopoiesis and lethal hemorrhages in mouse embryos heterozygous for a knocked-in leukemia gene CBFB-MYH11. Cell. 87: 687-96. PMID 8929537 DOI: 10.1016/S0092-8674(00)81388-4  0.438
1996 Crute BE, Lewis AF, Wu Z, Bushweller JH, Speck NA. Biochemical and biophysical properties of the core-binding factor alpha2 (AML1) DNA-binding domain. The Journal of Biological Chemistry. 271: 26251-60. PMID 8824275 DOI: 10.1074/Jbc.271.42.26251  0.367
1996 Wang Q, Stacy T, Binder M, Marín-Padilla M, Sharpe AH, Speck NA. Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis Proceedings of the National Academy of Sciences of the United States of America. 93: 3444-3449. PMID 8622955 DOI: 10.1073/Pnas.93.8.3444  0.376
1995 Hajra A, Liu PP, Wang Q, Kelley CA, Stacy T, Adelstein RS, Speck NA, Collins FS. The leukemic core binding factor β-smooth muscle myosin heavy chain (CBFβ-SMMHC) chimeric protein requires both CBFβ and myosin heavy chain domains for transformation of NIH 3T3 cells Proceedings of the National Academy of Sciences of the United States of America. 92: 1926-1930. PMID 7892201 DOI: 10.1073/Pnas.92.6.1926  0.416
1995 Zaiman AL, Lewis AF, Crute BE, Speck NA, Lenz J. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores. Journal of Virology. 69: 2898-906. PMID 7707514 DOI: 10.1128/Jvi.69.5.2898-2906.1995  0.387
1995 Sun W, Graves BJ, Speck NA. Transactivation of the Moloney murine leukemia virus and T-cell receptor β-chain enhancers by cbf and ets requires intact binding sites for both proteins Journal of Virology. 69: 4941-4949. PMID 7609063 DOI: 10.1128/Jvi.69.8.4941-4949.1995  0.392
1995 Wijmenga C, Speck NA, Dracopoli NC, Hofker MH, Liu P, Collins FS. Identification of a new murine runt domain-containing gene, Cbfa3, and localization of the human homolog, CBFA3, to chromosome 1p35-pter. Genomics. 26: 611-4. PMID 7607690 DOI: 10.1016/0888-7543(95)80185-O  0.322
1994 Wotton D, Ghysdael J, Wang S, Speck NA, Owen MJ. Cooperative binding of Ets-1 and core binding factor to DNA Molecular and Cellular Biology. 14: 840-850. PMID 8264651 DOI: 10.1128/Mcb.14.1.840  0.368
1994 Liu P, Seidel N, Bodine D, Speck N, Tarlé S, Collins FS. Acute myeloid leukemia with Inv (16) produces a chimeric transcription factor with a myosin heavy chain tail. Cold Spring Harbor Symposia On Quantitative Biology. 59: 547-53. PMID 7587111 DOI: 10.1101/Sqb.1994.059.01.061  0.305
1993 Wang S, Wang Q, Crute BE, Melnikova IN, Keller SR, Speck NA. Cloning and characterization of subunits of the T-cell receptor and murine leukemia virus enhancer core-binding factor. Molecular and Cellular Biology. 13: 3324-39. PMID 8497254 DOI: 10.1128/Mcb.13.6.3324  0.354
1993 Melnikova IN, Crute BE, Wang S, Speck NA. Sequence specificity of the core-binding factor. Journal of Virology. 67: 2408-11. PMID 8445737 DOI: 10.1128/Jvi.67.4.2408-2411.1993  0.338
1993 Sun W, O'Connell M, Speck NA. Characterization of a protein that binds multiple sequences in mammalian type C retrovirus enhancers. Journal of Virology. 67: 1976-86. PMID 8445719 DOI: 10.1128/Jvi.67.4.1976-1986.1993  0.334
1993 Manley NR, O'Connell M, Sun W, Speck NA, Hopkins N. Two factors that bind to highly conserved sequences in mammalian type C retroviral enhancers. Journal of Virology. 67: 1967-75. PMID 8445718 DOI: 10.1128/Jvi.67.4.1967-1975.1993  0.374
1992 Prosser HM, Wotton D, Gegonne A, Ghysdael J, Wang S, Speck NA, Owen MJ. A phorbol ester response element within the human T-cell receptor β-chain enhancer Proceedings of the National Academy of Sciences of the United States of America. 89: 9934-9938. PMID 1409722 DOI: 10.1073/Pnas.89.20.9934  0.405
1992 Redondo JM, Pfohl JL, Hernandez-Munain C, Wang S, Speck NA, Krangel MS. Indistinguishable nuclear factor binding to functional core sites of the T-cell receptor delta and murine leukemia virus enhancers. Molecular and Cellular Biology. 12: 4817-23. PMID 1328863 DOI: 10.1128/Mcb.12.11.4817  0.443
1992 Wang SW, Speck NA. Purification of core-binding factor, a protein that binds the conserved core site in murine leukemia virus enhancers. Molecular and Cellular Biology. 12: 89-102. PMID 1309596 DOI: 10.1128/Mcb.12.1.89  0.351
1990 Speck NA, Renjifo B, Golemis E, Fredrickson TN, Hartley JW, Hopkins N. Mutation of the core or adjacent LVb elements of the Moloney murine leukemia virus enhancer alters disease specificity. Genes & Development. 4: 233-42. PMID 2338244 DOI: 10.1101/Gad.4.2.233  0.305
1990 Renjifo B, Speck NA, Winandy S, Hopkins N, Li Y. cis-acting elements in the U3 region of a simian immunodeficiency virus. Journal of Virology. 64: 3130-4. PMID 2335831 DOI: 10.1128/Jvi.64.6.3130-3134.1990  0.347
1990 Golemis EA, Speck NA, Hopkins N. Alignment of U3 region sequences of mammalian type C viruses: identification of highly conserved motifs and implications for enhancer design. Journal of Virology. 64: 534-42. PMID 2153223 DOI: 10.1128/Jvi.64.2.534-542.1990  0.303
1990 Speck NA, Renjifo B, Hopkins N. Point mutations in the Moloney murine leukemia virus enhancer identify a lymphoid-specific viral core motif and 1,3-phorbol myristate acetate-inducible element. Journal of Virology. 64: 543-50. PMID 2104942 DOI: 10.1128/Jvi.64.2.543-550.1990  0.4
1987 Speck NA, Baltimore D. Six distinct nuclear factors interact with the 75-base-pair repeat of the Moloney murine leukemia virus enhancer. Molecular and Cellular Biology. 7: 1101-10. PMID 3561410 DOI: 10.1128/Mcb.7.3.1101  0.361
1982 Speck NA, Pierce SK. The induction of B cells refractory to antibody-specific immunoregulation European Journal of Immunology. 12: 449-452. PMID 6980129 DOI: 10.1002/Eji.1830120518  0.364
1982 Speck NA, Pierce SK. Antibody-specific immunoregulation is restricted by the major histocompatibility gene complex European Journal of Immunology. 12: 972-976. PMID 6217979 DOI: 10.1002/Eji.1830121114  0.372
1982 Speck NA, Pierce SK. The collaborative phenotype of secondary B cells is determined by T lymphocytes during in vivo immunization Journal of Experimental Medicine. 155: 574-586. PMID 6173458 DOI: 10.1084/Jem.155.2.574  0.383
1981 Pierce SK, Speck NA, Gleason K, Gearhart PJ, Köhler H. BALB/c T cells have the potential to recognize the TEPC 15 prototype antibody and its somatic variants Journal of Experimental Medicine. 154: 1178-1187. PMID 6974760 DOI: 10.1084/Jem.154.4.1178  0.369
Show low-probability matches.